Windlas Biotech Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- 347.85
- Today's High:
- 374.45
- Open Price:
- 373.05
- 52W Low:
- 52W High:
- Prev. Close:
- 370.7
- Volume:
- 5898
Company Statistics
- Market Cap.:
- 0
- Book Value:
- Revenue TTM:
- 0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- 0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Windlas Biotech Ltd had its IPO on under the ticker symbol WINDLAS*.
The company operates in the sector and industry. Windlas Biotech Ltd has a staff strength of 0 employees.
Stock update
Shares of Windlas Biotech Ltd opened at 373.05 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of 347.85 - 374.45, and closed at 357.9.
This is a -3.45% slip from the previous day's closing price.
A total volume of 5,898 shares were traded at the close of the day’s session.
In the last one week, shares of Windlas Biotech Ltd have slipped by -8.04%.
Windlas Biotech Ltd's Key Ratios
Windlas Biotech Ltd has a market cap of 0, indicating a price to book ratio of and a price to sales ratio of .
In the last 12-months Windlas Biotech Ltd’s revenue was 0 with a gross profit of 0 and an EBITDA of 0. The EBITDA ratio measures Windlas Biotech Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Windlas Biotech Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Windlas Biotech Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Windlas Biotech Ltd’s PE and PEG Ratio
- Forward PE
- Trailing PE
- PEG
Its diluted EPS in the last 12-months stands at per share while it has a forward price to earnings multiple of and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Windlas Biotech Ltd’s profitability.
Windlas Biotech Ltd stock is trading at a EV to sales ratio of and a EV to EBITDA ratio of . Its price to sales ratio in the trailing 12-months stood at .
Windlas Biotech Ltd stock pays annual dividends of per share, indicating a yield of and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- 0
- Total Liabilities
- 0
- Operating Cash Flow
- 0
- Capital Expenditure
- 0
- Dividend Payout Ratio
- 0%
Windlas Biotech Ltd ended 1970 with 0 in total assets and 0 in total liabilities. Its intangible assets were valued at 0 while shareholder equity stood at 0.
Windlas Biotech Ltd ended 1970 with 0 in deferred long-term liabilities, 0 in other current liabilities, in common stock, 0 in retained earnings and 0 in goodwill. Its cash balance stood at 0 and cash and short-term investments were 0. The company’s total short-term debt was 0 while long-term debt stood at 0.
Windlas Biotech Ltd’s total current assets stands at 0 while long-term investments were 0 and short-term investments were 0. Its net receivables were 0 compared to accounts payable of 0 and inventory worth 0.
In 1970, Windlas Biotech Ltd's operating cash flow was 0 while its capital expenditure stood at 0.
Comparatively, Windlas Biotech Ltd paid 0 in dividends in 1970.
Other key metrics
- Current Trading Price
- 357.9
- 52-Week High
- 52-Week Low
- Analyst Target Price
Windlas Biotech Ltd stock is currently trading at 357.9 per share. It touched a 52-week high of and a 52-week low of . Analysts tracking the stock have a 12-month average target price of .
Its 50-day moving average was 350.55 and 200-day moving average was 280.78 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.